Co-Authors
This is a "connection" page, showing publications co-authored by Changgui Li and Qihan Li.
Connection Strength
1.101
-
Randomized, Double-Blinded, Placebo-Controlled Phase 2 Trial of an Inactivated Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine in Healthy Adults. Clin Infect Dis. 2021 12 06; 73(11):e3949-e3955.
Score: 0.246
-
Immunological evaluation of an inactivated SARS-CoV-2 vaccine in rhesus macaques. Mol Ther Methods Clin Dev. 2021 Dec 10; 23:108-118.
Score: 0.241
-
The safety and immunogenicity of an inactivated SARS-CoV-2 vaccine in Chinese adults aged 18-59 years: A phase I randomized, double-blinded, controlled trial. Vaccine. 2021 05 12; 39(20):2746-2754.
Score: 0.235
-
Immunogenicity and Safety of an F-Genotype Attenuated Mumps Vaccine in Healthy 8- to 24-Month-Old Children. J Infect Dis. 2019 01 01; 219(1):50-58.
Score: 0.201
-
Immune Serum From Sabin Inactivated Poliovirus Vaccine Immunization Neutralizes Multiple Individual Wild and Vaccine-Derived Polioviruses. Clin Infect Dis. 2017 May 15; 64(10):1317-1325.
Score: 0.179